These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 964553)

  • 1. Effect of drug combination of antitumor activity and myelotoxicity.
    Fujimoto S; Inouye T; Tsukagoshi S
    Gan; 1976 Apr; 67(2):207-14. PubMed ID: 964553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of cytosine arabinoside and thiopurines.
    Valeriote F; Vietti T; Edelstein M
    Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S; Ogawa M; Hoshino A
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
    Fujimoto S; Inagaki J; Horikoshi N; Hoshino A
    Gan; 1977 Oct; 68(5):543-52. PubMed ID: 201534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ; Otter GM; Stock CC
    Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scheduling of arabinosylcytosine and 6-thioguanine therapy.
    LePage GA; White SC
    Cancer Res; 1973 May; 33(5):946-9. PubMed ID: 4703126
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic synergism elicited by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride: synergistic cytocidal activity against L1210 cells in vitro.
    Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):659-66. PubMed ID: 6939645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M; Herrlinger K; Schaeffeler E; Stange EF
    Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myelocytic leukemia.
    Holland JF; Glidewell O; Ellison RR; Corey RW; Schwartz J; Wallace HJ; Hoagland HC; Wiernik P; Rai K; Bekesi JG; Cuttner J
    Arch Intern Med; 1976 Dec; 136(12):1377-81. PubMed ID: 793552
    [No Abstract]   [Full Text] [Related]  

  • 14. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
    Grindey GB; Divekar AY; Hakala MT
    Cancer Res; 1973 Oct; 33(10):2459-63. PubMed ID: 4741936
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of allopurinol on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2790-4. PubMed ID: 1277189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
    Kataoka T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
    Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
    Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL; Uyeki EM
    J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.